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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S56returned to control levels when synovial ﬁbroblasts were co-incubated
with PGF2a inhibitor AL8810 whereas inhibition of TGFb signaling with
SB505124 had no effect. aSMA gene expression and collagen production
were unaffected by inhibition of TGFb or PGF2a signaling. The increased
synovial ﬁbroblast migration in response to FCM could not be counter-
acted by SB505124, but was partially counteracted by AL8810. Synovial
ﬁbroblast proliferation in response to FCM was unaffected either by
SB505142 or AL8810.
Conclusions: These results indicate that infrapatellar fat can contribute for
the development of synovial ﬁbrosis by increasing collagen production,
PLOD2 gene expression, cell proliferation and cell migration; all charac-
teristics of a ﬁbrotic process. Based on our results, not TGFb but the more
recently discovered pro-ﬁbrotic factor PGF2a seems partly responsible for
the observed effects.
96
EFFECT OF CHONDROITIN SULFATE ON THE FACTORS INVOLVED IN
SYNOVIAL INFLAMMATION
J. Martel-Pelletier, Sr. 1, F. Mineau, Sr. 1, E. Montell, Sr. 2, J. Vergés, Sr. 2,
J.-P. Pelletier, Jr. 1. 1Osteoarthritis Res. Unit, Univ. of Montreal Hosp. Res. Ctr.
(CRCHUM), Notre-Dame Hosp., Montreal, QC, Canada; 2 Pharmacological Res.
Unit, Scientiﬁc Med. Dept., Bioibérica, Barcelona, Spain
Purpose: Chondroitin sulfate (CS), an interesting candidate for the thera-
peutic treatment of osteoarthritis (OA), has been shown in clinical trials to
reduce swelling and effusion in knee OA. We thus aimed to further
investigate the effect of CS alone or in combination with glucosamine
sulfate (GS), an anti-COX-2 (celecoxib), or acetaminophen on some syno-
vial membrane anti-angiogenic and inﬂammatory factors.
Methods: Treatment with CS (200 mg/ml; CSbBio-Active, Bioibérica,
Spain), GS (5 mM), celecoxib or acetaminophen alone, and CS in combi-
nation with the other mentioned products was investigated on human OA
synovial ﬁbroblasts in the presence or absence of IL-1b at 10 and 100 ng/
ml. To determine whether CS has an additional effect with celecoxib or
acetaminophen, preliminary experiments were performed to ﬁnd
concentrations of these products that induced about a 50% reduction in
prostaglandin E2 production under IL-1b at 100 ng/ml. A concentration of
10 nM was found for celecoxib and 25 mM for acetaminophen. The
expression levels (real time PCR) and/or protein production of vascular
endothelial growth inhibitor (VEGI), thrombospondin-1 (TSP-1), hyalur-
onic acid (HA), secreted phospholipase 2 (sPLA2), and cytosolic phospho-
lipase 2 (cPLA2) were determined using speciﬁc primers (expression) and
ELISAs (protein).
Results: On the anti-angiogenic factors VEGI and TSP-1, IL-1b dose-
dependently decreased their levels. On cells under basal conditions or
treated with IL-1b, CS signiﬁcantly induced the levels of VEGI expression
and TSP-1 production. All the other products tested (GS, celecoxib, and
acetaminophen) alone had no effect or decreased these anti-angiogenic
factors, but in conjunctionwith CS their levels were signiﬁcantly increased.
HA productionwas slightly but signiﬁcantly increased by IL-1b at 10 ng/ml
and a heightened induction was found at 100 ng/ml. CS signiﬁcantly
increased HA under basal conditions and in the presence of IL-1b at 10 ng/
ml. GS had no effect and celecoxib and acetaminophen signiﬁcantly
decreased it. Concomitant incubation of CS with GS, celecoxib, or acet-
aminophen signiﬁcantly increased HA production. Interestingly, sPLA2,
which is considered an anti-inﬂammatory (resolving) factor, demonstrated
a signiﬁcant decrease under IL-1b. Incubation with CS alone and in
conjunction with celecoxib or acetaminophen signiﬁcantly increased its
level. The inﬂammatory factor cPLA2 showed signiﬁcantly decreased
expression levels by CS, GS, and the combination of CS and GS. IL-1b
markedly and signiﬁcantly increased it at both concentrations and under
IL-1b, CS alone had no effect, but in combination with GS, its level was
signiﬁcantly reduced.
Conclusions: The anti-inﬂammatory effect of CS appears to occur through
a number of mechanisms including the inhibition of the anti-angiogenic
factors TSP-1 and VEGI as well as sPLA2, a factor associated with an anti-
inﬂammatory effect, and through increasing HA production and
decreasing cPLA2. Importantly, these effects of CS occurred in the presence
of other products, even though those products alone had no or a reverse
effect.97
EXPRESSION OF SPECIFIC PATHWAYS IN THE INFLAMED SYNOVIAL
MEMBRANE OF OSTEOARTHRITIS PATIENT: IDENTIFICATION OF NEW
POTENTIAL KEY INTERMEDIATES
C. Lambert 1, J.-E. Dubuc 2, B. Hennuy 3, E. Montell 4, J. Vergés 4,
Y. Henrotin 1. 1Bone and Cartilage Res. Unit, Univ. of Liège, Liège, Belgium;
2Orthopaedic Dept., Cliniques Univ. Saint Luc, Brussels, Belgium; 3GIGA
Genomics Core Facility, Univ. of Liege, Liège, Belgium; 4 Pharmacological
Res. Unit, Scientiﬁc Med. Dept., Bioibérica, S.A, Barcelona, Spain
Purpose: Synovitis is a key factor in osteoarthritis (OA) pathophysiology,
contributing to both patient symptoms and disease progression. In this
study, using an original methodology comparing normal/reactive (N/R)
and inﬂammatory (I) synovial membranes zones, we investigated the gene
expression proﬁles of synovial cells from these areas and identiﬁed
differentially regulated pathways.
Methods: Synovial cells (SC) were isolated from OA synovial specimens
obtained from 12 patients undergoing knee replacement. The inﬂamma-
tory status of the synovial membrane was characterized by the surgeon
according to macroscopic criteria including the synovial vascularization,
the villi formation and the hypertrophic aspect of the tissue. At the surgery
time, the synovial membrane was dissected and biopsies from N/R and I
areas cultured separately for a period of 7 days. Total RNA was extracted
using the RNeasy Mini Kit. RNA purity and quality were evaluated using
the Experion RNA StdSens Analysis kit (Bio-rad Laboratories). Gene
expression proﬁling between N/R and I areas was performed using Illu-
mina's multi-sample format Human HT-12 BeadChip (Illumina Inc.).
Differential analysis was performed with the BRB array tools software.
Class Comparison test between N/R and I areas was based on paired t-test
where N/R and I were paired for each patient. The biological relevance of
up- and down-regulated genes was analyses with Ingenuity Pathways
Analysis (Ingenuity Systems). Western blot was performed to conﬁrm
certain intermediate expression.
Results: From among 47000 probes, 17500 were ﬁltered out. Probes with
a p-value below than 0.005 were chosen and classiﬁed as up- or down-
regulated ones. By this way, 896 differentially expressed genes between N/
R and I zoneswere identiﬁed. Among these, 576 geneswere upregulated (I/
NR > 1.5) and 320 downregulated (I/NR < 0.75). With Ingenuity Pathways
Analysis, a signiﬁcant number of the top ranking differentially expressed
genes were identiﬁed as inﬂammatory, Wnt and angiogenic pathways.
Interleukin (IL)-6 and -8, chemokines (CXCL1, CXCL2, CXCL5, CXCL6,
CXCL16) and arachidonate 5-lipoxygenase (ALOX5) were identiﬁed as the
most upregulated in I zones in the inﬂammatory pathway. Interestingly,
the alarmin S100A9 was found strongly upregulated in this pathway.
Wnt5A and LRP (Low density lipoprotein receptor-related protein) 5 were
upregulated whereas FZD (Frizzled homolog) 2 and DKK (dickkopf
homolog) 3 were downregulated in the Wnt signaling pathway. Finally,
stanniocalcin (STC)-1, an intermediate in angiogenesis was identiﬁed as
the most upregulated gene in I zones compared to N/R zones. This
difference of expression was conﬁrmed at the protein level.
Conclusions: Using a unique culture system, this study is the ﬁrst to
identify different expression pattern between two areas of synovial
membrane from the same OA patient. These differences concern several
key pathways involved in OA pathogenesis, i.e. inﬂammation, Wnt and
angiogenesis. This analysis also provided interesting information
regarding new potent intermediates as S100A9 and STC-1. They could be
potential targets for chondroitin sulfate, one of the most used molecules in
the management of OA. New experiments are being perfomed at the
moment to elucidate the potential effect of this molecule on these speciﬁc
differentially expressed genes in the same culture system.
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SYNOVIAL INFLAMMATION CORRELATES WITH MENISCAL PATHOLOGY
IN A COHORT OF PATIENTS UNDERGOING ACL RECONSTRUCTION FOR
TRAUMATIC ACL RUPTURE
M. Favero 1,2, J.L. Scott 1, C. Dragomir 1, R.F. Warren 1, M.K. Crow 1,
E. Attia 1, K. Bohnert 1, E.F. DiCarlo 1, S.R. Goldring 1, M.B. Goldring 1,
H.A. Jo 1, S.A. Rodeo 1. 1 The Hosp. for Special Surgery, Weill Cornell Med. Coll.,
ĂAbstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S57New York, NY, USA; 2Div. of Rheumatology, Dept. of Clinical and Experimental
Med., Univ. of Padova, Padova, Italy
Purpose: Previous epidemiologic studies have established that there is
a strong relationship between anterior cruciate ligament (ACL) disruption
and the risk for subsequent development of osteoarthritis (OA). Though
not normally considered a classical inﬂammatory arthropathy, OA is often
associated with low-grade synovitis. In patients with OA, synovial
inﬂammation is one factor associated with risk of progression of structural
joint deterioration and symptoms. The aims of the study were to charac-
terize the synovial features in patients undergoing ACL reconstruction
after traumatic ACL rupture and to determine the relationship between
inﬂammation and meniscal and cartilage abnormalities.
Methods: The studywas conducted in the context of the ACL registry at the
Hospital for Special Surgery, which maintains extensive records of
preclinical, intraoperative and post-operative data for 1200 patients who
have undergone ACL reconstruction for traumatic ACL rupture. Synovial
biopsies were collected from 40 patients during arthroscopic surgery and
processed for histology and RNA extraction. Synovial features of inﬂam-
mation, reaction, and degeneration were assessed using a combination
histological synovial scoring system developed at our institution in which
the following six features were graded: perivascular mononuclear cell
inﬁltration, detritus, mucoid change, ﬁbrosis, increased vascularity and
hyperplasia of the synovial lining layer leading to a total combined score of
15. The following clinical data were also collected: age, sex, BMI, date of
injury, time to surgery and the intraoperative presence or absence of
meniscal and/or cartilage abnormalities. Suprapatellar synovial levels of
mRNA for 4 chemokines (IL-8, CCL19, CCL21, and CCL5) and 1 chemokine
receptor (CCR7), shown previously to be associated with synovial inﬂam-
mation in patients undergoing meniscectomy by microarray pathway
analysis (C Scanzello A&R 2011), were measured by real-time PCR.
Results: Of the 40 patients undergoing synovial biopsy and analysis, 19
were female and 21 male, with mean ages of 29.1 and 38.4, respectively.
75% of the patients exhibited histological evidence of synovial inﬂamma-
tion in the suprapatellar area: 44.1% of patients scored 1 or 2, 44.1% scored
3 or 4, 5.8% scored 5 or 6, and 5.8% scored 7 or 8. Arthroscopically, meniscal
abnormalities (mostly tears) were observed in 19/40 patients (47%), and
cartilage defects were observed in 16/40 patients (40%). No associationwas
observed between the synovitis score and BMI, date of injury, time to
surgery, and frequency of cartilage defects or meniscal pathology. The
patients were divided in two groups based on age: 19 of patients older
than 30 years and 21 patients younger than 30 yr. Meniscal tears were
associated with synovial inﬂammation in patients older than 30 yr. 16
synovial suprapatellar biopsies from patients> 30 yr were chosen for qPCR
analysis, 8 each from patients without synovial inﬂammation (grade 0-2)
and with synovial inﬂammation (grade 3-8). The levels of CCL5 and CCL19
mRNA were signiﬁcantly upregulated in biopsy specimens exhibiting
inﬂammation with associated fold-changes of 2.7 (P¼0.0426) and 4.7
(P¼0.0289) respectively.
Conclusions: In our study, we observed a high percentage of low-grade
synovitis (75%), meniscal tear (47%) and/or cartilage defects (40%) in
patients undergoing ACL reconstruction for traumatic ACL rupture. In
a cohort of patients > 30 years old, the presence of synovitis correlated
with evidence of a meniscal tear, suggesting a relationship between these
two pathologic processes. Preliminary analysis of mRNA expression
patterns in this group of patients conﬁrmed the upregulation of CCL5 and
CCL19. This is in agreement with previously published data (C Scanzello
A&R 2011). These two chemokines may play an important contributory
role in the pathophysiology of OA particularly in those patients having
synovial inﬂammation.
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TYPE IIB PROCOLLAGEN N-PROPEPTIDE INHIBITS ANGIGENESIS IN
CARTILAGE
Z. Wang, J. Bryan, L. Sandell. Washington Univ., St. Louis, MO, USA
Purpose: A fragment of type II procollagen N-propeptide, PIIBNP, contains
the classic integrin binding sequence RGDRGD. This sequence is conserved
across species, indicating potential biological function. We have previously
shown that recombinant PIIBNP induces death of tumor cells that expressintegrin avb3 and avb5. Data from HUVEC cell tube formation assay, mouse
aortic ring assay and mouse corneal assay showed that recombinant
PIIBNP inhibits angiogenesis both in vitro and in vivo (1). PIIBNP is
synthesized by chondrocytes liberated to matrix in cartilage. The goal of
this study was to determine the role that PIIBNP plays in cartilage in
keeping cartilage avascular and intact.
Methods: Detection of PIIBNP from cartilage. Cartilage was isolated from
limbs of P1 mice. Cartilage was smashed by crusher and PIIBNP was
extracted with SDS loading buffer, resolved by SDS-PEGE, and detected by
western blotting.
Mouse chondrocyte isolation. Chondrocytes were obtained by enzymatic
dissociation of ventral regions of rib cages from newborn mice. Chon-
drocytes were incubated with or without the presence of MMP inhibitor
for 48 hours. The medium from chondrocytes culture were used as the
conditioned medium.
Cartilage-aorta co-culture: Bovine and mice bones were used as control in
the cartilage-aorta co-culture experiments. Mouse cartilage or bone was
placed into inserts of a 24-well plate and cocultured with aorta in 3D
matrigel for 8 days. The microvessel outgrowth was visualized under
a light microscope (NIKON ECLIPS E800) and images were digitally pho-
tographed using a Q capture Retiga 2000R camera, and quantiﬁed with an
Image J software.
Results: We have been able to detect PIIBNP in cartilage (Fig. 1A) and
chondrocytes conditioned medium (Fig. 1B). In order to reasonably
hypothesize an effect of PIIBNP in cartilage, we sought to determine
weather cartilage inhibits angiogenesis in mouse aortic ring assays. The
results from cartilage-aorta coculture experiments showed that micro-
vessel outgrowth was seen only in control and in the presence of bone, but
not in the presence of cartilage (Fig. 2A). Since we and other have detected
PIIBNP in cartilage, it is possible that the PIIBNP in cartilage inhibited the
microvessel outgrowth. To further conﬁrm this, we performed aorta
angiogenesis assay in the presence of chondrocyte conditioned medium
and found that the chondrocyte conditioned medium inhibited 80 percent
of the microvessel outgrowth as compared with the control (Fig B). MMT
inhibitor GM6001 inhibits the production of PIIBNP and the cartilage
treated with GM6001 did not inhibit microvessel outgrowth in mouse
aortic ring assay. These data suggested that natural PIIBNP in cartilage
inhibits angiogenesis.
To further investigate the mechanism behind the antiangiogenesis of
PIIBNP, we treated HUVEC cells in culture with recombinant proteins.
Treatments with PIIBNP, but not GSTor mPIIBNP, induced disappearance of
VE-cadherin at cell-cell junctions (Fig 3A), suggesting that the engagement
of PIIBNP on cell surface elicited a signaling events involved in the inhi-
bition of angiogenesis by PIIBNP. This hypothesis is supported by the fact
that the PIIBNP, but not GST or mPIIBNP, induced activation of the Src
kinase (Fig 3B), consistent with previous report that integrin avb3 signaling
induces Src activation and VE-cadherin internalization.
Conclusions: We previously showed that recombinant PIIBNP induced
tumor cell death via binding to integrin avb3 and avb5, and suppresses
tumor growth in nude mice. The data presented here suggested that the
natural occurring PIIBNP in cartilage most likely inhibits angiogenesis. We
have detected the existence of PIIBNP from P1 chondrocyte conditioned
mediumwhich also inhibits angiogenesis. Since PIIBNP reaches the highest
level during cartilage formation and it kills tumor cell, it is an excellent
candidate for the molecular mechanism by which cartilage remains
avascular and intact.
